<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine</dc:title>
  <dc:creator>Garavito, G.</dc:creator>
  <dc:creator>/Bertani, St&#xE9;phane</dc:creator>
  <dc:creator>Quiliano, M.</dc:creator>
  <dc:creator>Valentin, A.</dc:creator>
  <dc:creator>Aldana, I.</dc:creator>
  <dc:creator>/Deharo, Eric</dc:creator>
  <dc:subject>antimalarials</dc:subject>
  <dc:subject>methylene blue</dc:subject>
  <dc:subject>drug combination</dc:subject>
  <dc:description>The effectiveness of methylene blue (MB) combined with pyrimethamine (PYR), chloroquine (CQ) or quinine (Q) was examined in a classical four-day suppressive test against a causative agent of rodent malaria, Plasmodium berghei. A marked potentiation was observed when MB was administered at a non-curative dose of 15 mg/kg/day in combination with PYR (0.19 mg/kg/day) or Q (25 mg/kg/day). No synergy was found between MB (15 mg/Kg) and CQ (0.75 mg/Kg). Our results suggest that the combination of MB with PYR or Q may improve the efficacy of these currently used antimalarial drugs.</dc:description>
  <dc:date>2012</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010057237</dc:identifier>
  <dc:identifier>fdi:010057237</dc:identifier>
  <dc:identifier>Garavito G., Bertani St&#xE9;phane, Quiliano M., Valentin A., Aldana I., Deharo Eric. The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine. 2012, 107 (6),  820-823</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>
